Whitehawk Therapeutics Inc
General ticker "WHWK" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $99.1M (TTM average)
Whitehawk Therapeutics Inc follows the US Stock Market performance with the rate: 42.0%.
Estimated limits based on current volatility of 3.3%: low 3.40$, high 3.63$
Factors to consider:
- Price in estimated range
Stock Forecast*
* forecast is subjective and experimental, should not be used for any investment decisions
Long term estimates were made for the period from 2025-12-31 to 2027-12-31
- 2025-12-31 to 2026-12-31 estimated range: [1.70$, 4.26$]
- 2026-12-31 to 2027-12-31 estimated range: [1.55$, 3.91$]
Short-term WHWK quotes
Long-term WHWK plot with estimates
Financial data
| YTD | 2023-12-31 | 2024-12-31 | 2025-12-31 |
|---|---|---|---|
| Operating Revenue | $24.35MM | $25.98MM | $7.14MM |
| Operating Expenses | $96.29MM | $93.44MM | $121.55MM |
| Operating Income | $-71.93MM | $-67.46MM | $-114.40MM |
| Non-Operating Income | $6.17MM | $3.77MM | $93.80MM |
| Interest Expense | $0.23MM | $0.15MM | $0.00MM |
| R&D Expense | $48.93MM | $51.03MM | $90.96MM |
| Income(Loss) | $-65.77MM | $-63.69MM | $-20.60MM |
| Profit(Loss)* | $-65.77MM | $-63.69MM | $-20.60MM |
| Stockholders Equity | $105.19MM | $52.48MM | $136.31MM |
| Inventory | $6.43MM | $5.31MM | $0.00MM |
| Assets | $132.42MM | $70.32MM | $150.83MM |
| Operating Cash Flow | $-59.66MM | $-59.55MM | $-97.43MM |
| Capital expenditure | $3.97MM | $1.65MM | $0.55MM |
| Investing Cash Flow | $83.21MM | $25.20MM | $11.89MM |
| Financing Cash Flow | $0.33MM | $0.13MM | $94.38MM |
| Earnings Per Share** | $-2.44 | $-2.36 | $-0.33 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.